Liquid Biopsy, By Target Analyte (Circulating Tumor Cells, Circulating Tumor DNA, Exosomes, Nucleosomes), By Analytical (Molecular, Proteomic, Histology/Imaging), By Application (Routine Screening, Patient Work Up, Early-Stage Disease, Late Stage/Metastatic Disease), By Sample (Blood, Urine), By Cancer Type (Breast Cancer, Lung Cancer, Brain Cancer, Prostate Cancer, Colorectal Cancer), By End-User (Research Laboratories, Academia, Research Centers, Hospitals) and By Region - Global Industry Perspective Comprehensive Analysis and Forecast, 2022-2028


 Request Customization  Sample Request  Ask for Discount
 MDHE15IV6EUM  |    May 25, 2020


Liquid biopsy is a fluid biopsy that analyzes the non-solid biological tissues majorly in blood. A liquid biopsy is majorly used in clinical and laboratory research to find-out and measure the biomarkers. These blood-based tests enable researchers to identify the unique characteristics of the cancer cell. The liquid biopsy is a technique used as a diagnostic and monitoring tool to diagnose diseases like cancer. The liquid biopsy also takes multiple samples of drugs to validate the efficiency of cancer treatment. The technology may also beneficial to monitor patient conditions after treatment. The liquid biopsy is an advanced treatment procedure for cancer. The global liquid biopsy market is growing rapidly due to the increasing demand for minimally invasive surgeries and rising healthcare expenditure. The major issues with tissue biopsies are the procedure is invasive and it may be difficult to obtain tissues based on location.



The report offers detailed coverage of Liquid Biopsy market and industry trends to provide a comprehensive view of the market. The Liquid Biopsy research report includes market estimation & forecasting, demand & supply analysis, price trends, company market share of the leading players in Liquid Biopsy market. The report splits the market based on various segments. The Liquid Biopsy market report also describes the main players and how they are strengthening their position in the market with the latest innovations, strategic acquisitions, partnership and collaboration. It also provides the financial analysis, SWOT analysis, company overview and portfolio analysis of the leading players in the Liquid Biopsy market. 

  • Biocept
  • Cynvenio
  • NeoGenomics Laboratories
  • Qiagen
  • Trovagene
  • RainDance Technologies
  • Guardant Health
  • Exosome Diagnostics
  • SAGA Diagnostics AB
  • Circulogene Theranostics
  • Inivata
  • Agena Bioscience
  • Admeria Health Personal Genome Diagnostics
  • Adaptive Biotechnologies

Liquid Biopsy Segments

The Liquid Biopsy market is segmented as below

Segmentation

Target Analyte

  • Circulating Tumor Cells
  • Circulating Tumor DNA
  • Exosomes
  • Nucleosomes

Analytical

  • Molecular
  • Proteomic
  • Histology/Imaging

Application

  • Routine Screening
  • Patient Work Up
  • Early-Stage Disease
  • Late Stage/Metastatic Disease

Sample

  • Blood
  • Urine

Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Brain Cancer
  • Prostate Cancer
  • Colorectal Cancer

End-User

  • Research Laboratories
  • Academia
  • Research Centers
  • Hospitals

The Liquid Biopsy market report brings market data at one point to understand the Liquid Biopsy market growth trends, market size, and future scenario of the market. This analysis will help clients to plan their expansion, investment, merger acquisition strategy and bring the improvement. All the data of Liquid Biopsy market is demonstrated in such a way that the end-user can leverage the analyzed data. The analysis includes all segment and sub-segment analysis and their scope, growth rate, market opportunities and challenges. 



The qualitative analysis of Liquid Biopsy market report includes competitive landscape, key growth, and restraining factors. In addition to this, the PESTEL, Porter's Five, and Value chain analysis enables users to understand how the micro and macro-economic factors have influenced the Liquid Biopsy market.  The global analysis of Liquid Biopsy market report allows users to understand the competitive factors in the market, which help them to take strategic business decisions for sustainable growth. 

In Liquid Biopsy market report the top-down and bottom-up approach has applied to estimate the market value. In the top-down and bottom-up approach, the report considered primary and secondary research. In the primary research, multiple interviews were conducted with CEOs, CFOs, and product managers of the leading players. The interviews also include the subject matter expert, investors, and end-user interviews. Secondary research includes company annual reports, press releases, whitepapers, market players’ association news portal, government portal, and journals. 

Market Density

Market Density is one-stop market research, advisory, consulting and, industry analysis reports platform. The reports' library providing business data and intelligence information on thousands of micro as well as high growth markets with global as well as regional coverage. Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for B2B, B2C, and government organizations around the globe. Market Density helps global clients to deal with the business challenges in the competitive world for sustainable growth.

Contact information:

4340 Stevens Creek Blvd,
Suite # 172.
San Jose, CA 95129
Ph : +1 669 264 1656
Email : sales@marketdensity.com

 

  • About Us
    • Why Should you buy this report (sample)
    • How this report delivers? (sample)
    • Key Questions Answered(sample)
  • Chapter 1: Introduction to Liquid Biopsy Market
    • Market Definition
    • Market Segmentation
    • Macro Economic Factor Analysis
  • Chapter 2: Executive Summary
  • Chapter 3: Market Factor Analysis
    • Porter’s Five Forces Analysis
    • PESTEL Analysis
    • Value Chain Analysis
    • SWOT Analysis
    • Pricing Analysis
  • Chapter 4: Global Liquid Biopsy Market Estimation & Forecast By Target Analyte
    • Circulating Tumor Cells
    • Circulating Tumor DNA
    • Exosomes
    • Nucleosomes
  • Chapter 5: Global Liquid Biopsy Market Estimation & Forecast By Analytical
    • Molecular
    • Proteomic
    • Histology/Imaging
  • Chapter 6: Global Liquid Biopsy Market Estimation & Forecast By Application
    • Routine Screening
    • Patient Work Up
    • Early-Stage Disease
    • Late Stage/Metastatic Disease
  • Chapter 7: Global Liquid Biopsy Market Estimation & Forecast By Sample
    • Blood
    • Urine
  • Chapter 8: Global Liquid Biopsy Market Estimation & Forecast By Cancer Type
    • Breast Cancer
    • Lung Cancer
    • Brain Cancer
    • Prostate Cancer
    • Colorectal Cancer
  • Chapter 9: Global Liquid Biopsy Market Estimation & Forecast By End-User
    • Research Laboratories
    • Academia
    • Research Centers
    • Hospitals
  • Chapter 10 Global Liquid Biopsy Market Estimation & Forecast By Region
    • North America
    • Asia Pacific
    • Europe
    • EMEA
    • Latin America
  • Chapter 11 Competitive Landscape
    • Competition Mapping
    • Company Profiles (Suppliers)
      • Biocept
      • Cynvenio
      • NeoGenomics Laboratories
      • Qiagen
      • Trovagene
      • RainDance Technologies
      • Guardant Health
      • Exosome Diagnostics
      • SAGA Diagnostics AB
      • Circulogene Theranostics
  • Chapter 12 Recommendations
  • Chapter 13 Acronyms and Assumptions

Purchase options

Single User $ 2100.00
Corporate User $ 3000.00